PuSH - Publikationsserver des Helmholtz Zentrums München

Kraus, K.M. ; Eichner, R.* ; Combs, S.E.

Kombination Radio(chemo)therapie beim Lungenkarzinom – Nebenwirkungsmanagement.

Combined chemoradiotherapy in lung cancer—Management of side effects.

Best Pract. Onkol. 18, 496-507 (2023)
DOI
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Simultaneous chemoradiotherapy (CRT) is the standard treatment for locally advanced non-small cell lung cancer (NSCLC) in stage III and for limited stages of small cell lung cancer (SCLC) and nonoperability. The side effects depend on the cytotoxic agents employed, the radiotherapeutic parameters and the patient characteristics. This article summarizes and discusses the management strategies for frequent and relevant side effects of CRT of lung cancer. The chemotherapy mostly includes a highly emetogenic platinum derivative. Therefore, prophylaxis of chemotherapy-associated nausea and vomiting with serotonin 5‑hydroxytryptamine‑3 (5-HT3) and neurokinin 1 (NK1) receptor antagonists and dexamethasone is an essential element of peritherapeutic management. The management of likewise primary chemotherapy-induced hematologic side effects depends on the severity and the affected blood cell lineage and involves growth factors and blood transfusions. In contrast, radiotherapy-induced alterations, especially of the lungs and esophagus can mostly not be causally treated but are treated symptomatically. The prophylaxis and treatment of the broad spectrum of side effects of CRT of lung cancer should be based on a thorough evaluation of the severity of symptoms, the treatment efficacy and associated risks.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Anemia ; Esophagitis ; Nausea ; Pneumonitis ; Quality Of Life
ISSN (print) / ISBN 0946-4565
Zeitschrift Best Practice Onkologie
Quellenangaben Band: 18, Heft: 11, Seiten: 496-507 Artikelnummer: , Supplement: ,
Verlag Springer
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Radiation Medicine (IRM)